NOVAREX Co.,Ltd. (KOSDAQ:194700)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,760.00
+60.00 (0.62%)
At close: Apr 22, 2025, 3:30 PM KST
1.88%
Market Cap 171.53B
Revenue (ttm) 297.73B
Net Income (ttm) 23.02B
Shares Out 17.70M
EPS (ttm) 1,300.00
PE Ratio 7.45
Forward PE n/a
Dividend 200.00 (2.05%)
Ex-Dividend Date Dec 27, 2024
Volume 39,886
Average Volume 59,377
Open 9,780.00
Previous Close 9,700.00
Day's Range 9,690.00 - 9,880.00
52-Week Range 6,650.00 - 11,770.00
Beta 0.28
RSI 63.21
Earnings Date May 15, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 417
Stock Exchange KOSDAQ
Ticker Symbol 194700
Full Company Profile

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.

Financial Statements

News

There is no news available yet.